Reuters logo
BRIEF-Aveo announces submission of response to Tivozanib marketing authorization application day 180 list of outstanding issues
2017年4月13日 / 中午12点13分 / 7 个月前

BRIEF-Aveo announces submission of response to Tivozanib marketing authorization application day 180 list of outstanding issues

April 13 (Reuters) - Aveo Pharmaceuticals Inc:

* Aveo announces submission of response to tivozanib marketing authorization application day 180 list of outstanding issues

* Aveo Pharma - EUSA remains tentatively scheduled to provide oral explanation to EMA’s committee for medicinal products for human use at May 2017 meeting Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below